BEXIMCO PHARMA.GDR REGS 1 (R2WA) — Net Asset Momentum
BEXIMCO PHARMA.GDR REGS 1 (R2WA) recorded a net asset momentum of 9.0% as of June 2024, with net assets of €51.90 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check R2WA goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
BEXIMCO PHARMA.GDR REGS 1 Net Asset Momentum (2021–2024)
This chart tracks BEXIMCO PHARMA.GDR REGS 1's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is +9.0%, with net assets of €51.90 Billion EUR as of June 2024. Read how much debt does BEXIMCO PHARMA.GDR REGS 1 carry for a breakdown of total debt and financial obligations.
Annual Net Asset History for BEXIMCO PHARMA.GDR REGS 1 (2021–2024)
The table below shows the complete annual net asset history for BEXIMCO PHARMA.GDR REGS 1 from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see R2WA stock market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €51.90 Billion | €69.34 Billion | €17.44 Billion | ▲ +9.0% |
| 2023 | €47.62 Billion | €69.16 Billion | €21.54 Billion | ▲ +6.7% |
| 2022 | €44.64 Billion | €66.15 Billion | €21.51 Billion | ▲ +19.5% |
| 2021 | €37.36 Billion | €52.25 Billion | €14.88 Billion | — |